Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 19

Results For "inter"

3453 News Found

ParexelAI launched to accelerate clinical development and improve trial efficiency
Clinical Trials | May 19, 2026

ParexelAI launched to accelerate clinical development and improve trial efficiency

The platform combines internally developed technologies, strategic partnerships, and external AI capabilities


MedGenome to expand integrated diagnostics access across Mumbai suburbs
Healthcare | May 19, 2026

MedGenome to expand integrated diagnostics access across Mumbai suburbs

Collaboration with Siddhi Diagnostics combines genomics and advanced imaging capabilities to strengthen precision diagnostics in high-growth suburban markets


Manipal Hospital launches ‘Oorja’ Support Group for celiac awareness in children
Hospitals | May 19, 2026

Manipal Hospital launches ‘Oorja’ Support Group for celiac awareness in children

Initiative focuses on early diagnosis, gut health awareness and long-term gluten-free care for children with celiac disease


India’s top scientific minds discuss  preparedness against emerging health threats
Policy | May 19, 2026

India’s top scientific minds discuss preparedness against emerging health threats

Discussions during the meeting focused on strengthening India’s preparedness against zoonotic diseases and climate-sensitive health challenges


India’s opportunity to build preventive healthcare economy
Opinion | May 19, 2026

India’s opportunity to build preventive healthcare economy

The country’s strength lies not just in technology availability but in adoption behaviour


HAB Pharma, Signature Phytochemicals merge to form Rs. 600 crore integrated pharma entity
News | May 19, 2026

HAB Pharma, Signature Phytochemicals merge to form Rs. 600 crore integrated pharma entity

Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026


Cupid shatters FY26 guidance with record 93% revenue jump & 165% profit surge
News | May 19, 2026

Cupid shatters FY26 guidance with record 93% revenue jump & 165% profit surge

Growth was driven by expansion across key business segments, improving efficiencies, and sustained demand across institutional and retail channels


Teva study exposes major diagnosis gap in Tardive Dyskinesia
R&D | May 19, 2026

Teva study exposes major diagnosis gap in Tardive Dyskinesia

According to the analysis, just 23% of patients aged 18–29 were formally diagnosed with TD